Leonidas C Platanias

  • 21754 Citations
1985 …2024
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

chronic leukemias, multiple myeloma, non-hodgkin's lymphoma

Certifications and Licenses

Internal Medicine
Medical Oncology

Training Experience

1984Residency, Hellenic Anticancer Institute
1989Residency, SUNY/State University of New York Downstate Medical Center
1992Fellowship, University of Chicago Hospitals

Education/Academic qualification

PhD, University of Patras Medical School

… → 1989

MD, University of Patras Medical School

… → 1983

Research interests

  • Leukemia
  • Lymphomas
  • Multiple Myeloma

Fingerprint Dive into the research topics where Leonidas C Platanias is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Interferons Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
Interferon Type I Medicine & Life Sciences
Phosphorylation Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Sirolimus Medicine & Life Sciences
Chemical activation Chemical Compounds
p38 Mitogen-Activated Protein Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2001 2024

Immunoprecipitation
Immunoblotting
Small Interfering RNA
Transfection
Phosphotransferases
Glioblastoma
Therapeutics
Neoplasms
Growth
Heterografts
Cyclin-Dependent Kinase 9
Protein Transport
Acute Myeloid Leukemia
Protein Biosynthesis
Heterografts
grant
cancer
funding
scientific journal
pilot project

Research Output 1985 2019

Discovery of novel Mnk inhibitors using mutation-based induced-fit virtual high-throughput screening

Mishra, R. K., Clutter, M. R., Blyth, G. T., Kosciuczuk, E. M., Blackburn, A. Z., Beauchamp, E. M., Schiltz, G. E. & Platanias, L. C., Oct 1 2019, In : Chemical Biology and Drug Design. 94, 4, p. 1813-1823 11 p.

Research output: Contribution to journalArticle

Screening
Phosphotransferases
Throughput
Acute Myeloid Leukemia
Mutation
2 Citations (Scopus)

Identification and targeting of novel CDK9 complexes in acute myeloid leukemia

Beauchamp, E. M., Abedin, S. M., Radecki, S. G., Fischietti, M., Arslan, A. DI., Blyth, G. T., Yang, A., Lantz, C., Nelson, A., Goo, Y. A., Akpan, I., Eklund, E. A., Frankfurt, O., Fish, E. N., Thomas, P. M., Altman, J. K. & Platanias, L. C., Jan 1 2019, In : Blood. 133, 11, p. 1171-1185 15 p.

Research output: Contribution to journalArticle

Cyclin-Dependent Kinase 9
Sirolimus
Acute Myeloid Leukemia
Cytoplasm
Chemical activation
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints

Nora Vaz Saleiro, D. & Platanias, L. C., Jan 1 2019, (Accepted/In press) In : Seminars in Immunology. 101299.

Research output: Contribution to journalReview article

Interferons
Cytokines
Neoplasms
Antineoplastic Agents
Gene Expression

Natural killer cell activity and survival after azacitidine treatment in high-risk MDS

Abedin, S. M. & Platanias, L. C., Aug 24 2019, In : Leukemia and Lymphoma. 60, 10, p. 2343-2344 2 p.

Research output: Contribution to journalComment/debate

Azacitidine
Natural Killer Cells
Cell Survival